Culture

Mouse IL-10: What It Is and Why It Matters in Immunology

By 4 min read 577 views
Featured image for Mouse IL-10: What It Is and Why It Matters in Immunology

Mouse IL-10 at a Glance

Mouse IL-10 is a pleiotropic cytokine best known for dampening excessive immune responses. Produced by a range of cell types, it helps keep inflammation in check and prevents tissue damage during infection. Researchers rely on mouse models of IL-10 to study autoimmune disease, allergy, cancer, and chronic infection, making it one of the most studied immunomodulatory molecules in the laboratory.

More from this site

Keep reading the latest coverage

Browse latest →

In mice, the Il10 gene encodes a 178-amino-acid protein that is secreted primarily as a homodimer. The protein signals through a receptor complex made of IL-10R1 and IL-10R2, both members of the class II cytokine receptor family. Binding triggers the JAK1–TYK2–STAT3 pathway, which drives the expression of anti-inflammatory genes and suppresses pro-inflammatory mediators such as TNF-α, IL-1β, and IL-6.

Which Cells Make Mouse IL-10

Mouse IL-10 is not limited to a single cell type. Key producers include:

  • Regulatory T cells (Tregs), which use IL-10 to enforce peripheral tolerance.
  • Macrophages and dendritic cells, which secrete it to limit collateral tissue damage during infection.
  • CD4+ T helper cells, particularly Th2 and Tr1 subsets, that deploy IL-10 to fine-tune the immune response.
  • B cells, which can generate IL-10 to modulate antibody production and inflammatory cascades.
  • Mast cells and certain innate lymphoid cells, contributing to early-phase regulation.

How Mouse IL-10 Signaling Works

The IL-10 receptor complex is expressed on most hematopoietic cells. When IL-10 binds, it recruits JAK1 and TYK2 kinases, which phosphorylate STAT3. Phosphorylated STAT3 dimerizes and translocates to the nucleus, where it activates genes that suppress antigen presentation, reduce co-stimulatory molecule expression, and block the production of pro-inflammatory cytokines. This feedback loop is essential for resolving inflammation after an immune threat has been cleared.

Mouse IL-10 in Disease Models

Because of its powerful anti-inflammatory action, IL-10 is central to many disease models. In colitis research, Il10-knockout mice spontaneously develop intestinal inflammation resembling human inflammatory bowel disease. In allergy models, IL-10 helps regulate IgE responses and prevent airway hyperreactivity. In cancer, the cytokine can be both protective and detrimental, depending on the tumor microenvironment: it can restrain anti-tumor immunity or, in other contexts, limit chronic inflammation that promotes tumor growth.

IL-10 and Infection

During chronic infections, mouse IL-10 can be a double-edged sword. On one hand, it prevents immunopathology by restraining T-cell overactivation. On the other hand, pathogens such as Leishmania and certain viruses exploit IL-10 to evade clearance. Studies in Il10-deficient mice have shown faster pathogen control but also increased tissue damage, highlighting the delicate balance IL-10 maintains between protection and pathology.

Research Tools and Techniques

Scientists use several tools to study mouse IL-10 in the lab. Recombinant mouse IL-10 protein is widely used for in vitro stimulation assays. Anti-IL-10 and anti-IL-10R blocking antibodies allow researchers to neutralize the cytokine and observe the resulting immune response. Knockout and conditional knockout mouse lines (including Il10 floxed models for Cre-mediated deletion) provide in vivo systems to dissect cell-type-specific functions. Flow cytometry, qPCR, and ELISA are standard methods for measuring IL-10 production in tissues and cultured cells.

Translational Relevance

Findings from mouse IL-10 research have informed clinical strategies in humans. Recombinant human IL-10 has been tested in trials for Crohn's disease and other inflammatory conditions, and mouse studies continue to guide dosing, route of administration, and patient selection. Understanding how IL-10 interacts with checkpoint inhibitors in cancer immunotherapy is another active area, with mouse models helping to predict whether enhancing or blocking IL-10 will improve treatment outcomes.

Key Comparisons

AttributeDetailContext
GeneIl10Chromosome 1 in C57BL/6 mice
Protein size178 amino acids, ~17 kDaSecreted as a disulfide-linked homodimer
Receptor complexIL-10R1 + IL-10R2Expressed on most hematopoietic cells
Primary signaling pathwayJAK1–TYK2–STAT3Drives anti-inflammatory gene expression
Key producersTregs, macrophages, Th2 cells, B cellsContext-dependent in different tissues
Knockout phenotypeSpontaneous colitisUsed to model IBD

Takeaway

Mouse IL-10 remains a cornerstone of immunology research. Its ability to suppress inflammation, shape adaptive immunity, and influence disease outcomes makes it indispensable for understanding both normal immune regulation and pathological states. Continued work with refined genetic tools and disease models promises to deepen insights into therapeutic applications targeting the IL-10 pathway.

Editor's pick

Keep exploring our latest stories

Fresh reads, picked daily.

Browse latest
Share: